Home > Healthcare > Medical Services > Surgical Services > Vaginal Rejuvenation Market
Vaginal Rejuvenation Market size valued at USD 1 billion in 2019 and is projected to grow at over 33.7% between 2020 and 2026.
The growing popularity of vaginal rejuvenation procedures among women across the globe is propelling the market growth. Increasing prevalence of stress urinary incontinence and desire to enhance female genitals are some other factors that have uplifted the market revenue. Furthermore, rising marketing and commercialization of the vaginal procedures is one of the significant drivers for accelerating the overall market expansion.
In the recent past years, there has been an upsurge in the non-invasive procedures that includes lasers as contrary to the conventional surgical techniques. However, due to the severe adverse effects of these devices the regulatory bodies including Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK and the U.S. Food and Drug Administration (FDA) have warned the medical devices companies. These regulatory bodies have warned the companies against the use of energy-based devices to perform vaginal rejuvenation procedures. These bodies have not approved devices for use in this procedure.
Report Attribute | Details |
---|---|
Base Year: | 2019 |
Vaginal Rejuvenation Market Size in 2019: | 997.0 Million (USD) |
Forecast Period: | 2020 to 2026 |
Forecast Period 2020 to 2026 CAGR: | 33.7% |
2026 Value Projection: | 5,022.1 Million (USD) |
Historical Data for: | 2015 to 2019 |
No. of Pages: | 120 |
Tables, Charts & Figures: | 232 |
Segments covered: | Treatment and End-use |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
In addition, the global COVID-19 pandemic has changed the practice of vaginal rejuvenation procedures. According to the American Society of Plastic Surgeons, due to COVID-19 pandemic the suspension of elective and non-essential procedures is carried out across the country. During this pandemic, elective surgeries have been cancelled or postponed decreasing the risk of patients being exposed to COVID-19 in hospital, thereby supporting the hospitals, clinics, surgical centers, and others in converting operating theatres into intensive care procedure.